Tethis S.p.A announces the release of See.d, the first universal blood sample preparator for liquid biopsy analysis. This innovative technology performs a completely automated...
Novo Holdings A/S, a leading international life sciences investor, announces that its portfolio company F2G Ltd. (F2G) has entered into a strategic collaboration with...
Atamyo Therapeutics, a biotechnology company focused on the development of new-generation gene therapies targeting neuromuscular diseases, announced multiple major milestones for ATA-100 and ATA-200,...
Axion BioSystems, a leading life science tools company focused on advanced live-cell assay platforms, announces that Kevin Gould has been appointed the company’s Chief...
ReCode Therapeutics, a biopharmaceutical company powering the next wave of genetic medicines through superior delivery presented new preclinical data from the company’s inhaled mRNA-based...
